Blackrock Neurotech is a team of the world’s leading engineers, neuroscientists, and visionaries. Our mission is simple: We want people with neurological disorders to walk, talk, see, hear, and feel again. We’re engineering the next generation of neural implants, including implantable brain-computer interface technology that restores function and independence to individuals with neurological disorders. Join us in changing lives today.
Connect with us:
Join Our Team | https://bit.ly/3bCsXRv
LinkedIn | https://bit.ly/3PfifOL
Twitter | https://bit.ly/3PfifOL
Instagram | https://bit.ly/3bMaYrW
Facebook | https://bit.ly/3JRc2av
Clinical Trials | https://bit.ly/3A8QPWm
Our site | https://blackrockneurotech.com
Additional information:
As the world leader in BCI tech, our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer’s, Parkinson’s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders. Our systems can be optimized from the ground up to handle even the most challenging applications.
Our BCI is the most sophisticated and long-tested human BCI, interfacing with the brain and empowering independence in those with paralysis & other neurological disorders since 2004. In fact, dozens of patients have used our BCI for a collective 30,000+ days to regain freedom through movement and communication. Our first commercial BCI, MoveAgain, received a Breakthrough Designation from the FDA in 2021 and is expected to be commercially available in 2023.
Join us in changing lives today.
Compumedics, founded in 1987, is a global leader in the design & manufacture of innovative diagnostic technologies for sleep disorders, neurophysiology & cardiology.
In 1987, Compumedics established Asia Pacific’s first fully computerised sleep lab and holds 80% share of the Australian sleep-diagnostic market, and has a major & rapidly growing presence in the US, European & Asian markets for its sleep, neurological, & Doppler blood flow diagnostic monitoring devices.
In 1995, the company was selected to supply equipment to the US Sleep Heart Health Study, the world’s largest sleep study of its kind, currently exceeding 14,000 studies with 20,000 patients scheduled by 2008. With headquarters in Melbourne, Australia & offices in the US & Europe, the products are distributed in over 50 countries. Achievements include :
1998 Australian Exporter of the Year
2000 Listed on the Australian Stock Exchange
2002 Acquired US-based Neuroscan, the world's leading supplier of instruments for brain research. Neuroscan holds about 90% of the USA market for brain research products
2003 Frost & Sullivan Award for Market Expansion Strategy
2004 Acquired German-based DWL Elektronishe GmbH
2006 Frost & Sullivan Technology Leadership award for the innovative Somté
2007 Victorian Manufacturing Hall of Fame
2008 The DWL division received the top 100 German Innovation award
2009 Design award for its Grael™ PSG/EEG premium lab solution
2010 Recognised as Australia's top 100 health innovators
2011 Established direct presence in France, awarded several significant USA contracts to supply preeminent USA customers with NeuvoLTM EEG
2012 Celebrated 25 year silver jubilee anniversary ,CURRY7 and Neuvo 512 LTM EEG system released
2013 Equity issued to Beijing Bestmed, its long-term partner in China
2014 Released Upgrade to the world leading diagnostics software platform for Sleep and EEG, ProFusion
2015 Core business strengthens and returns to strong operating profitability
BrainCo’s leadership draws on deep experience in neuroscience research and expertise in education to deliver entirely new applications of brainwave technology in the education, wellness, and research spaces. We’ve learned important lessons as we’ve grown from a small team in an apartment basement to over 100 employees in 4 offices around the world. Since 2015 we’ve been working on providing the best experience possible for our customers and we’re here to share our progress and innovations with you.